InvestorsHub Logo

Monroe1

11/02/20 2:47 PM

#127516 RE: Blueheel1 #127514

Management will provide an update on recent clinical and regulatory developments regarding COVID-19 and other indications for leronlimab.

Hard to say. I sure appreciate the transparency. I would venture to predict there will be something about UK or Philippines moving ahead depending on the 75% data and not waiting until the end of trial. Could be a surprise move for HIV too from UK. I agree about no approval yet or we would have a PR and 8k instead. I am looking forward to hearing from Mahboob.

Dieselpro

11/02/20 2:53 PM

#127518 RE: Blueheel1 #127514

Could be they have started enrollment in UK covid and update on UK BLA